Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1BORTEZOMIB[1] Bortezomib[1] D03150 (Name: Bortezomib)[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[17] 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331
2Bortezomib (Velcade®)[1] Bortezomib[1] D03150 (Name: Bortezomib)[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 66
3Bortezomib Accord[1] Bortezomib[1] D03150 (Name: Bortezomib)[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28
4Bortezomib D-mannitol[2] Bortezomib,
Mannitol		[2] D00062 ,
D03150 (Name: Bortezomib)		[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28
5Bortezomib Injection[1] Bortezomib[1] D03150 (Name: Bortezomib)[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 64
6Bortezomib/dexamethasone[2] Bortezomib,
Dexamethasone		[2] D00292 ,
D03150 (Name: Bortezomib)		[2] NR3C1,
PSMB5 💬		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 283
7Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone[2] Bortezomib,
Dexamethasone		[2] D00292 ,
D03150 (Name: Bortezomib)		[2] NR3C1,
PSMB5 💬		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28
8Combination of a single dose anti-CD20 antibody and bortezomib[1] Bortezomib[1] D03150 (Name: Bortezomib)[1] PSMB5 💬[8] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 61
9Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[4] D00287 ,
D00292 ,
D03150 (Name: Bortezomib),
D07760 		[2] NR3C1,
PSMB5 💬		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28
10Cyclophosphamide, Bortezomib, dexamethasone[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[4] D00287 ,
D00292 ,
D03150 (Name: Bortezomib),
D07760 		[2] NR3C1,
PSMB5 💬		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28
11Cyclophosphamide, Bortezomib, dexamethasone plus Daratumumab[4] Bortezomib,
Cyclophosphamide,
Daratumumab,
Dexamethasone		[5] D00287 ,
D00292 ,
D03150 (Name: Bortezomib),
D07760 ,
D10777 		[3] CD38,
NR3C1,
PSMB5 💬		[16] Alzheimer disease, Amyotrophic lateral sclerosis, Calcium signaling pathway, Hematopoietic cell lineage, Huntington disease, Metabolic pathways, Neuroactive ligand-receptor interaction, Nicotinate and nicotinamide metabolism, Oxytocin signaling pathway, Pancreatic secretion, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Salivary secretion, Spinocerebellar ataxia 💬[1] 28
12SoC: cyclophosphamide, bortezomib, and Dexamethasone (CyBorD)[3] Bortezomib,
Cyclophosphamide,
Dexamethasone		[4] D00287 ,
D00292 ,
D03150 (Name: Bortezomib),
D07760 		[2] NR3C1,
PSMB5 💬		[9] Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬[1] 28